Fox Chase Cancer Center Offers Free Information Session for Women Interested in New Breast Cancer Prevention Study
PHILADELPHIA (June 30, 1999) -- Fox Chase Cancer Center is offering a free information session about the new breast cancer prevention trial called STAR. The session will be held Tuesday, July 13 at 6:30pm in room C at Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia. The STAR trial will compare the drugs tamoxifen and raloxifene. Tamoxifen is already proven effective in reducing the incidences of breast cancer in high-risk women. Raloxifene may be as good or better in lowering the risk of the disease in some women.
The STAR trial is open and currently recruiting participants. Only postmenopausal women at increased risk of developing breast cancer are eligible for the study.
To attend the information session, please call 215-728-4750 or 1-888-FOX CHASE.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).